Of the many different types of malignant or benign tumors out there, malignant brain tumors are considered among the rarest. ...

Among cancer survivors, excess body weight is associated with an increased risk for a second primary malignant neoplasm, ...

A former "Real Housewives of Beverly Hills" star will be undergoing serious surgery after doctors found a tumor. The post ...

Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence ("AI") company developing targeted and transformative cancer ...

Lantern Pharma has won a trio of rare-pediatric-disease designations from the Food and Drug Administration for its investigational drug candidate LP-184 in multiple ultra-rare children's cancers.

Celiac disease presents a higher risk for developing malignant neoplasms, including small intestine, lymphoma, and skin ...

The findings, published in Nature Immunology, indicate that tumors edit the activity of multiple genes to avoid immune ...

Recent data shows that areas with high radon levels may increase the incidence of non-malignant tumors up to 26% and strokes ...

Lantern was granted these rare pediatric disease designations in: malignant rhabdoid tumors (MRT), rhabdomyosarcoma (RMS), and hepatoblastoma. Lantern's investigational drug candidate, LP-184, has ...

A study has discovered that recurrent tumors of the aggressive brain cancer glioblastoma multiforme (GBM) grow out of the fibrous scars of malignant predecessors destroyed by interventions such as ...

The FDA has approved Keytruda in combination with pemetrexed and platinum chemotherapy, as first-line Tx of unresectable advanced or metastatic malignant pleural mesothelioma.

Regardless of a tumor's size, the most concerning aspect of having one is whether it is cancerous, also known as malignant. Fortunately, about 90% of tumors are noncancerous, also known as benign.